University of Crete (UOC)
Η συμβολή των σπινθηρογραφικών απεικονίσεων (ουσίες επισημασμένες με Tc-99m) στη διάγνωση και παρακολούθηση των ασθενών με ιδιοπαθείς φλεγμονώδεις εντερικές νόσους
Abstract
dc:descriptionAim: The mean purpose of this study was to evaluate and compare Tc99m (V) DMSA to Tc-99m HMPAO WBC scintigraphy in the detection, assessment of disease activity and follow up of patients with active IBD. Upon confirmation of Tc-99m (V) DMSA contribution in the detection of bowel inflammation, we additionally evaluated its role in the diagnosis of ischemic colitis. Subjects-Method: Tc-99m (V) DMSA scintigraphy was performed in 23 patients with clinically and endoscopically confirmed active IBD and true positive Tc-99m HMPAO WBC scintigraphy. The interval between the scintigraphic studies ranged from 2-3 days 370 MBq (10 mCi) Tc-99m HMPAO WBC and 555 MBq (15 mCi) Tc-99m (V) DMSA was i.v. injected in all patients. With the patient in the supine position, planar views of the abdomen were obtained 2 hours after Tc-99m HMPAO WBC and 4 hours after Tc-99m (V) DMSA injection. The bowel was divided in 5 segments: small bowel, ascending colon, transverse colon, descending colon and rectosigmoid. Images were considered positive when an area of increased uptake was observed. To assess severity of IBD, semiquantitative measurements were included with reference to the uptake in the iliac crest. For the second part of the study we examined 14 patients with endscopically confirmed ischemic colitis. Imaging was performed after i.v. injection of 555 MBq (15 mCi) Tc-99m (V) DMSA. The whole process of imaging and scintigraphic evaluation did not differ from that for IBD patients. Results: In all IBD cases Tc-99m HMPAO WBC scans were positive and correlated with endoscopic findings. Tc-99m (V) DMSA scintigraphic findings were compared with Tc-99m HMPAO WBC findings in 135 segments. Tc-99m (V) DMSA findings were in full agreement with Tc-99m HMPAO WBC concerning 98 bowel segments and in disagreement in 37. The k statistics were as follows: good agreement for the small bowel and the ascending colon, moderate agreement for the transverse, descending and rectosigmoid. With regard to ischemic colitis, in 3 out of 14 patients, the Tc-99m (V) DMSA scintigraphy showed moderate uptake in the bowel. Compared to endoscopic findings, radionuclide images were in agreement with the segments concerned. In the other 11 patients, Tc-99m (V) DMSA scintigraphy revealed no increased uptake in the bowel at all. Conclusion: The results confirm that Tc-99m (V) DMSA could provide a useful non-invasive alternative method for the assessment of disease activity in patients with IBD. However, it is inferior to Tc-99m HMPAO WBC scintigraphy especially in the evaluation of disease localization. With regard to the second part of the study, our data suggest that Tc99m (V) DMSA has no role in the detection and diagnosis of ischemic colitis.
Degree
thesis:*- Grantor dc:publisher
- University of Crete (UOC)
- Year dc:date
- 2008
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Stathaki, Maria
- Σταθάκη, Μαρία
Subjects
dc:subject × 19- Σπινθηρογράφημα
- Ιδιοπαθείς φλεγμονώδεις εντερικές νόσοι
- Λευκοκύτταρα επισημασμένα με Tc-99m HMPAO
- Κολίτιδα, ισχαιμική
- Διάγνωση
- Διαχρονική παρακολούθηση
- Ραδιοφάρμακα
- Tc-99 (V) DMSA
- SCINTIGRAPHY
- Inflammatory bowel diseases (IBD)
- Tc-99m HMPAO labeled leukocytes
- Colitis, Ischemic
- Diagnosis
- Follow up
- Radiotracer
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/24941